Is United Therapeutics Corporation (UTHR) Stock Worth a Buy Monday?
Monday, September 20, 2021 03:15 PM | InvestorsObserver Analysts
Mentioned in this article
United Therapeutics Corporation (UTHR) stock has gained 95.56% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives UTHR stock a score of 66 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 97. UTHR's rank also includes a long-term technical score of 81. The fundamental score for UTHR is 20. In addition to the average rating from Wall Street analysts, UTHR stock has a mean target price of $233.38. This means analysts expect the stock to climb 18.14% over the next 12 months.
UTHR has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on UTHR!
United Therapeutics Corporation (UTHR) stock is lower by -1.27% while the S&P 500 has fallen -2.65% as of 3:12 PM on Monday, Sep 20. UTHR has fallen -$2.54 from the previous closing price of $200.08 on volume of 154,228 shares. Over the past year the S&P 500 is up 31.52% while UTHR has gained 95.56%. UTHR earned $10.28 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 19.21.
Click Here to get the full Stock Report for United Therapeutics Corporation stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
